This HTML5 document contains 209 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1111/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38773634
rdf:type
wikibase:Item
schema:description
teaduslik artikkel บทความทางวิทยาศาสตร์ ৩ মে ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artigo científico wetenschappelijk artikel articolo scientifico 2016年論文 наукова стаття, опублікована в травні 2016 2016年论文 2016年の論文 scientific article published on 3 May 2016 научни чланак tudományos cikk мақолаи илмӣ vitskapeleg artikkel artykuł naukowy artikulong pang-agham 2016年论文 2016年論文 научна статия articol științific 2016 nî lūn-bûn wissenschaftlicher Artikel vetenskaplig artikel artikel ilmiah სამეცნიერო სტატია vědecký článek 2016年论文 vedecký článok artigo científico 2016年論文 vitenskapelig artikkel bilimsel makale naučni članak tieteellinen artikkeli artículo científico publicado en 2016 2016年论文 2016 թվականի մայիսի 3-ին հրատարակված գիտական հոդված 2016年論文 scienca artikolo научни чланак artigo científico article scientifique article científic مقالة علمية نشرت في 3 مايو 2016 2016년 논문 2016年论文 научная статья scientific article published on 3 May 2016 bài báo khoa học artikull shkencor artículu científicu espublizáu en 2016 2016年论文 2016年論文 article scientific videnskabelig artikel מאמר מדעי scientific article published on 3 May 2016 επιστημονικό άρθρο
p:P577
wds:Q38773634-8BA1DC4E-83D1-4E41-845F-C69310719057
wdt:P577
2016-05-03T00:00:00Z
p:P2860
wds:Q38773634-059DA1D5-7504-42C3-A0DB-ED39942E3C4E wds:Q38773634-0973E1EA-8330-46DE-9A70-67840908736F wds:Q38773634-114DF252-A8BD-4FD9-A775-BAAB6AA71E24 wds:Q38773634-1278D454-37AE-4B62-B1DA-9C6785E76B70 wds:Q38773634-19C3F948-08D0-4851-A2DD-866B20B622BF wds:Q38773634-258FD92C-F88D-4B99-BE09-8447B5C00350 wds:Q38773634-00CBE774-525E-4CC7-A492-58A475F97C61 wds:Q38773634-BCFC6D9F-426B-4961-A950-88B5F6E026A0 wds:Q38773634-BE495F82-6D7D-4B69-A7D3-F5C6442DDF1A wds:Q38773634-BF45A4A8-B7EB-4FA3-B32E-BBE11D002499 wds:Q38773634-C005EF89-BA58-477A-BD67-2D38005E0D5F wds:Q38773634-C413EC32-3743-4A83-B939-A8FD7FB94139 wds:Q38773634-C517A81E-43FB-4A88-83F5-83A4027A9A82 wds:Q38773634-C6BC17D6-8958-4DC2-AC6E-D27C8536A607 wds:Q38773634-A53F64F7-EB79-4590-81A3-69F44F72CD5A wds:Q38773634-A68E2DBA-38DB-4450-A146-50667996B171 wds:Q38773634-AAC20916-F43B-4174-BB75-2B56CB82819E wds:Q38773634-AC5C6B2A-51D0-49B5-87AD-2915F5FA29D2 wds:Q38773634-ADF776E6-C737-4148-A6BE-364581C12F56 wds:Q38773634-B2B2F957-88ED-4E42-B94D-A8B35990C7C7 wds:Q38773634-B3A0E0CB-91E0-48BB-B072-B8859996E0A8 wds:Q38773634-EBBD5937-B038-469C-AF18-BF28903780AF wds:Q38773634-C759C71A-BECC-4840-9AAB-5AC92558E2C2 wds:Q38773634-C8D591C2-1C84-4A07-9BEB-B6214ABD664A wds:Q38773634-CAE1779C-5721-4F21-9478-7DBFA9615F91 wds:Q38773634-D6FB8CEA-6248-456F-A061-C27F6FD0F5A3 wds:Q38773634-DA060B95-3045-4C86-8A6C-D82870F90111 wds:Q38773634-E6E8103C-EB0B-4332-86C4-E88F3894592F wds:Q38773634-5AE2E18E-BD4E-42FA-AC15-2F0C805F61A0 wds:Q38773634-5C3A1416-CEEB-4F64-BA14-245BB3B87488 wds:Q38773634-5CE9B5BB-2FD3-4249-B104-5F5CBF7D2283 wds:Q38773634-61C94C59-91CF-4EF3-8414-06DA03B5AC7A wds:Q38773634-62A82E18-A000-48E5-9E5F-D4E6BA51C688 wds:Q38773634-2BAEB048-8AE9-46B0-B682-39704CF22BD7 wds:Q38773634-3240D5DB-578C-4970-BC60-CF6FC480067F wds:Q38773634-351637BA-ABC4-4154-9CE8-67CF9AE0C518 wds:Q38773634-3C01312C-AF9E-4301-9A8A-1EECF0AC3AE3 wds:Q38773634-490C5437-1E7C-422A-9EA0-A8ECABA500EA wds:Q38773634-4D2540D9-467E-497A-9FC2-D15F8555A525 wds:Q38773634-86D7FD2E-0C3D-440F-8B35-C70B9EF23F6E wds:Q38773634-886DA909-CD5D-4746-9520-B6715C81EDF2 wds:Q38773634-89632844-5F6A-492D-9DE3-892E1912095C wds:Q38773634-90021879-74B5-4492-87C7-AA1529A904F4 wds:Q38773634-968508D4-1EFE-409A-A08F-F81210AA3EB6 wds:Q38773634-99FA8994-53ED-4378-8E59-37D42A4D8CEF wds:Q38773634-6D94B880-5787-4435-8A56-A2CAAA267CDC wds:Q38773634-7E1B287C-263B-4794-9FFB-448C39C9EC04 wds:Q38773634-82E77ADC-D08A-4FCB-B371-D2EBDE9D4353 wds:Q38773634-83C877E8-D050-4474-A277-C76396673522 wds:Q38773634-83F40D19-7103-46B6-B655-2391B2FB88C8
wdt:P2860
wd:Q37229596 wd:Q51857270 wd:Q34245284 wd:Q81404971 wd:Q37908692 wd:Q40909295 wd:Q37309407 wd:Q40529844 wd:Q39924656 wd:Q39332698 wd:Q33877432 wd:Q45098501 wd:Q51204482 wd:Q40761949 wd:Q28341882 wd:Q40352960 wd:Q33161027 wd:Q39695835 wd:Q36438027 wd:Q84216195 wd:Q39961766 wd:Q33292777 wd:Q45868903 wd:Q40815989 wd:Q39808317 wd:Q38807901 wd:Q53634741 wd:Q33775399 wd:Q42079022 wd:Q25938984 wd:Q35652096 wd:Q77553386 wd:Q73260063 wd:Q40920874 wd:Q39160823 wd:Q36151381 wd:Q35737519 wd:Q37092020 wd:Q39206532 wd:Q48231603 wd:Q33359930 wd:Q82829017 wd:Q39650175 wd:Q67684815 wd:Q46181868 wd:Q68966439 wd:Q72609210 wd:Q37084449 wd:Q43177005 wd:Q87388932
p:P2093
wds:Q38773634-8FC1C609-42E0-4A56-BD41-3ED67068E838 wds:Q38773634-E7006519-0AE0-448A-840A-29E11A419B51 wds:Q38773634-AABBEB34-7359-42A1-9F62-816567357ED0 wds:Q38773634-048C5AEA-D17B-40E4-B694-1F5FC0045D3A
wdt:P2093
Mathias Tesson Colin Nixon Robert J Mairs John W Babich
rdfs:label
Preliminary evaluation of prostate-targeted radiotherapy using (131) I-MIP-1095 in combination with radiosensitising chemotherapeutic drugs Preliminary evaluation of prostate-targeted radiotherapy using (131) I-MIP-1095 in combination with radiosensitising chemotherapeutic drugs Preliminary evaluation of prostate-targeted radiotherapy using (131) I-MIP-1095 in combination with radiosensitising chemotherapeutic drugs
skos:prefLabel
Preliminary evaluation of prostate-targeted radiotherapy using (131) I-MIP-1095 in combination with radiosensitising chemotherapeutic drugs Preliminary evaluation of prostate-targeted radiotherapy using (131) I-MIP-1095 in combination with radiosensitising chemotherapeutic drugs Preliminary evaluation of prostate-targeted radiotherapy using (131) I-MIP-1095 in combination with radiosensitising chemotherapeutic drugs
schema:name
Preliminary evaluation of prostate-targeted radiotherapy using (131) I-MIP-1095 in combination with radiosensitising chemotherapeutic drugs Preliminary evaluation of prostate-targeted radiotherapy using (131) I-MIP-1095 in combination with radiosensitising chemotherapeutic drugs Preliminary evaluation of prostate-targeted radiotherapy using (131) I-MIP-1095 in combination with radiosensitising chemotherapeutic drugs
p:P50
wds:Q38773634-41D67D98-0C9F-4672-950E-74FFD77D03ED
wdt:P50
wd:Q57628906
p:P1476
wds:Q38773634-58B79820-6317-42A0-A58F-AA6222865F32
wdt:P1476
Preliminary evaluation of prostate-targeted radiotherapy using (131) I-MIP-1095 in combination with radiosensitising chemotherapeutic drugs
p:P304
wds:Q38773634-CC8127B8-F55C-4EC7-BB2E-F38A8BE466B7
wdt:P304
912-921
p:P31
wds:Q38773634-0B4260E1-6CAF-43C2-A987-5E1F285B241F
wdt:P31
wd:Q13442814
p:P921
wds:Q38773634-833F6F26-1042-4197-A1B4-688B7D90270E
wdt:P921
wd:Q974135
p:P698
wds:Q38773634-58762A4A-9B6B-4EAC-86DE-8A692475D394
wdtn:P698
n11:27139157
wdt:P698
27139157
p:P1433
wds:Q38773634-600B8B16-7B11-4DC4-AD0B-D12ABB162579
wdt:P1433
wd:Q10532762
p:P433
wds:Q38773634-55B92683-9BB9-47F7-8A75-2457134EA781
p:P478
wds:Q38773634-D52FFB52-F5E4-49F5-8F88-B878FE1D8694
wdt:P433
7
wdt:P478
68
p:P356
wds:Q38773634-C4D5205C-0713-494E-84B3-0735A95DCC21
wdtn:P356
n12:JPHP.12558
wdt:P356
10.1111/JPHP.12558
p:P275
wds:Q38773634-7627c615-8c22-4cfe-bcbb-bf8163335e9a
p:P6216
wds:Q38773634-e77d78a9-0642-4966-9435-1caab62b0243
wdt:P275
wd:Q24082749
wdt:P6216
wd:Q50423863
p:P4510
wds:Q38773634-10E9E1D5-57C0-4B75-9A97-0B99A6130AC7
wdt:P4510
wd:Q1659584
p:P932
wds:Q38773634-7743D0A2-E676-45EB-BC3E-E46D31E3A405
wdt:P932
5298040